Skip to main content

Table 2 Antibiotyping of S. aureus isolates (MSSA and MRSA) from KZN province, South Africa.

From: Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa

MRSA (n = 61) No. of MRSA (%)**
Antibiotype* Resistance patterns  
  PEN GM EM TE TM CIP MUP CHL RF  
1 + + + + + + + +   4 (6.6)
2 + + + + + +    + 1 (1.6)
3 + + + + +   +   + 3 (4.9)
4 + + + + +    + + 4 (6.6)
5 + + + + + + +    6 (9.8)
6 + +   + +    + + 2 (3.3)
7 + +   + +   +   + 2 (3.3)
8 + + + + +     + 25 (41.0)
9 + + + +      + 1 (1.6)
10 + +   + +     + 5 (8.2)
11 +    +      + 2 (3.3)
12 + + +        6 (9.8)
MSSA (n = 166)  
  PEN GM EM TE TM CIP MUP CHL RF  
1 + + +   +      1 (0.6)
2 +   + +   +     1 (0.6)
3 +   + + +      4 (2.4)
4 +   +   +      1 (0.6)
5 +   +      +   1 (0.6)
6     + +   +    1 (0.6)
7 +   + +       2 (1.2)
8 +    + +      3 (1.8)
9 + +    +      5 (3.0)
10 +         + 1 (0.6)
11 +    +       2 (1.2)
12 +     +      3 (1.8)
13 +   +        9 (5.4)
14 +          114 (68.7)
15 SUSCEPTIBLE TO ALL ANTIBIOTICS 18 (10.8)
  1. KEY
  2. PEN: Penicillin; GEN: Gentamicin; EM: Erythromycin; TE: Tetracycline; TM: Trimethoprim; CIP: Ciprofloxacin; MUP: Mupirocin (5 μg); CHL: Chloramphenicol; RF: Rifampicin.
  3. * Number of antibiotypes in MRSA and MSSA isolates.
  4. ** Percentages in parentheses are based on the total number of isolates in each group (MRSA n = 61; MSSA n = 166).